Fig. 1From: Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysisDaily cases per million for alternative vaccine coverage levels, with and without moderate NPIs. Vaccine with 88% efficacy assumed for all ages. R0 =6.0. Median value of 100 simulations presented, with 10th and 90th percentile as shaded areasBack to article page